Indications & Dosage

Indications:

Susceptible Organism
Co-Amoxiclav (AMOXIVEE) is a bactericidal to a wide range of Gram-positive and Gram-negative organisms including many clinical important ß-lactamase producing penicillin resistant pathogens: Staphylococcus epidemids Streptococcus pyogenes, Streptococcus pneumonia, Streptococcus viridians, Streptococcus faecalis, Listeria monocytogenes, Bacillus anthracis, Corynebacterium species, Clostridium species, Peptococcus species, Peptostreptococcus species Escherichia Coli Proteus vulgaris Klebsiella species Salmonella species Shigelia species, Bordetelia pertussis Haemophilus influenza, Brucella species Neisseria gonorrhea Yersinia enterocolitica, Gardinerella vaginalis Branhamella catarrhalis Haemophilus ducreyi, Pasteuralla multocida, Campylobacter leiuni, Vibrio choleae Bacteroides species including Bacteroides fragilis ( including ß-lactamase producing strains resistant to ampicillin and amoxicillin) Co-Amoxiclav (AMOXICARE) is indicated in the treatment of common bacterial infections where antibiotics theraphy is
indicated, including: Tonsilitis, Sinusitis, Otitis Media, acute and chronic bronchitis, pneumonia, thoracic emphysema, lung abscess, boils and abscesses, cellulites, wound infection, intra-abdominal sepsis, cyctitis, urethritis, nephropyelitis, septic abortion, pelvic infection, chancroid, gonorrhea, osteomyelitis.

Dosage and Administration

The usual adult dose is 1 tablet three times a day or as prescribed by the physician.